The Frontalis Muscle · Anatomy and Treatment Logic
What you will find here: the anatomy of the only eyebrow elevator, the mechanism of action, the Cotofana 12-zone topography, individual dosing logic, and complications with a focus on brow ptosis and the Spock sign. Booking and fee information on the treatment page.
The horizontal forehead lines are produced by a single muscle — the frontalis. It is the only elevator of the eyebrows and thus the direct antagonist of the glabellar region. When the glabellar depressors are selectively weakened while the frontalis remains intact, a medial brow lift results — the desired therapeutic effect. Anyone wanting to understand forehead treatment must understand this antagonism — it explains why isolated weakening of the frontalis is problematic and why the forehead is almost always treated together with the glabella.
The only elevator muscle of the eyebrows
Anatomically, the forehead muscle is correctly called the venter frontalis of the occipitofrontalis muscle — part of a paired muscle that runs across the calvaria. Clinically it is usually referred to simply as the frontalis muscle. Its essential property: it is the only eyebrow elevator. All other muscles around the eyebrows are brow depressors.
| Property | Description |
|---|---|
| Origin | Galea aponeurotica at the level of the hairline |
| Course | Vertical, running in parallel across the entire forehead region |
| Insertion | Superciliary arch of the frontal bone, and interwoven with the muscle fibres of the glabellar complex |
| Function | Raising the eyebrows, wrinkling the forehead skin (horizontal forehead lines) |
| Innervation | Temporal and zygomatic branches of the facial nerve |
The medial and lateral fibre portions of the frontalis behave differently clinically: the medial fibres primarily produce the horizontal line in the centre of the forehead, while the lateral fibres determine the shape of the eyebrows. Treatment must take this division into account — exclusively medial weakening can lead to a surprised lateral elevation of the eyebrow (the “Spock sign”).
Why the forehead and glabella are anatomical antagonists
The frontalis muscle pulls the eyebrows upward. The three muscles of the glabellar region (corrugator supercilii, procerus, depressor supercilii) pull them downward. In the neutral face, these forces balance each other.
Weakening only one of the two antagonists shifts the balance — and that is usually clinically undesirable:
| Treatment | Consequence |
|---|---|
| Frontalis alone | The depressors gain the upper hand → eyebrows drop (“heavy brow,” brow ptosis) |
| Glabella alone | The frontalis gains the upper hand → eyebrows are subtly raised (medial brow lift) — usually desired or neutral |
| Both regions together | Reduced expression in both regions, muscle balance preserved — this is the consensus standard |
Treatment of the horizontal forehead lines can and should be carried out at the same time as treatment of the vertical frown lines (glabellar region). Simultaneous treatment of both regions is often essential for a harmonious overall result.— Consensus recommendations on the use of botulinum toxin A in aesthetic medicine, 2007
In practice this means: anyone who comes wanting forehead-line treatment is, during the consultation, almost always also advised to have a glabellar treatment — not out of cross-selling logic, but out of muscle-physiological necessity. An isolated forehead treatment is the exception — for example in young patients with a high brow position and only mild forehead lines.
Mechanism of action at the neuromuscular junction. How botulinum toxin type A acts in the muscle (binding, internalisation, cleavage of SNAP-25, functional block) is described in detail in the in-depth editorial on the glabellar complex — the mechanism at the frontalis is identical to that at all other muscles of facial expression. The regional differences lie not in the mechanism of action, but in the anatomy and the dosing logic.
The Cotofana 12-zone topography
The classic injection patterns from the 1990s describe fixed points: 4–6 injection sites in a horizontal line, supplemented by a second line for a tall forehead. This pattern works for many patients — but it ignores the anatomical variability of the individual frontalis musculature.
The anatomical map published by Cotofana and de Maio in 2018 divides the frontalis muscle into 12 anatomical zones — six on each side, in three rows (cranial, middle, caudal) and two columns (medial, lateral). Each zone has its own average activity pattern during voluntary expression, which is assessed individually in the patient:
| Zone | Typical activity | Dosing logic |
|---|---|---|
| Mediocranial | Very active when frowning the forehead, produces the main line | Main injection region, higher per-point dose |
| Laterocranial | Variable, often the Spock-sign region | Dose carefully, “counter-Mephisto point” if needed |
| Mediocaudal | Active, but a minimum distance of 1–2 cm from the orbital rim is critical | Reduced dose, cautious |
| Laterocaudal | Lateral brow elevator, frequently very active | Risk of brow ptosis if treated; dose only minimally |
Why there is no standard dose
The 2007 consensus recommendations give initial doses that are to be understood as ranges, not as blanket values:
Pattern options
The basic pattern for horizontal forehead lines is a horizontal line across the middle of the forehead with 4–6 injection points. With a tall forehead or pronounced muscle activity, a second line is added at a distance of 1.5–2 cm, with a further 2–4 points (“additional points for a tall forehead”).
Factors in individual dose-finding
- Forehead height and muscle mass. Tall forehead = more muscle area = often two injection lines.
- Brow position relative to the orbital rim. If the brow sits on or below the orbital rim → relative contraindication. If it sits clearly above → treatable without restriction.
- Sex. Men often need somewhat more active substance. But not automatically — individual muscle activity decides.
- Age and frontalis compensation. In older patients, the frontalis often compensates for a pre-existing brow ptosis through constant sustained contraction. Weakening it can lead more noticeably to visible brow drop here.
- Desire for retained residual expression. Patients who want to keep their forehead expression in conversation receive a lower dose than those who want a complete pause in expression.
Brow ptosis and other undesired effects
For forehead treatment, the most important information for patients is: a certain degree of brow drop almost always occurs. The 2007 consensus recommendations put it this way:
When the frontalis muscle is treated, the eyebrow always drops to some extent (heavy brow). Brow ptosis is therefore the most common undesired treatment effect.— Consensus recommendations 2007
The task is not to eliminate brow ptosis — that is impossible without undoing the treatment effect itself. The task is to limit it to an aesthetically inconspicuous degree. Three strategies for this:
Avoiding pronounced brow ptosis
- A minimum distance of 1, better 2 cm from the upper orbital rim. This is the most important clinical protective factor. Injections closer to the orbital rim increase the risk of diffusion toward the levator palpebrae superioris muscle and can also trigger a true eyelid ptosis.
- Co-treatment of the glabellar depressors. The muscle balance is preserved — the glabellar component does not pull the brows down, and the frontalis component does not pull them up.
- Treat very deep horizontal lines with filler rather than botulinum toxin where appropriate. The lowest horizontal line is anatomically often structurally altered (collagen breakdown). A hyaluronic acid filler can often achieve more here than additional muscle weakening.
Spock sign — the unwanted elevation of the eyebrow
The “Spock sign” describes a surprised, questioning expression caused by a lateral elevation of the eyebrows — it arises when the medial frontalis is strongly weakened while the lateral fibres remain strongly active. Clinical correction: a minimal additional injection laterally into the frontalis (“counter-Mephisto point”) — often 0.5–1 U per side is enough.
Other undesired effects
- Bruising at injection sites (common, 3–7 days)
- Transient pressure pain or headache (1–2 days)
- A “rigid,” dry forehead — at higher doses, due to additional inhibition of sweat production in the forehead skin
- “Mephisto eyebrow,” “comma line” of the lateral forehead — from uneven weakening
- Residual lines with very deeply etched static forehead lines — the skin itself is structurally altered, but the dynamic component is reduced
- True eyelid ptosis (very rare, approx. 1–3 % of all frontalis treatments): from diffusion toward the levator palpebrae superioris muscle. Treatable with alpha-adrenergic eye drops (apraclonidine) until the effect wears off.
What forehead treatment is not
Four precise distinctions
- It is not a brow lift. The opposite occurs: the brows tend to drop slightly. Anyone wanting a brow lift should primarily consider a glabellar treatment — there the depressors are weakened, which subtly raises the brows.
- It is not a standalone procedure. Weakening the frontalis without treating the glabella shifts the muscle balance. In most cases both regions are treated together — see Section 2.
- It does not fully remove deep static lines. Very deeply etched forehead lines have a structural skin component (collagen breakdown, loss of elastin). Botulinum toxin reduces the dynamic line — for the static residual marking, a hyaluronic acid filler or other skin-regeneration therapies can be added.
- It is not suitable for everyone. Patients with brows on or below the bony orbital rim are a relative contraindication. Pre-existing brow ptosis must be documented before treatment and discussed with the patient. Treatment is not performed before a planned blepharoplasty — the surgical planning would be distorted by the toxin effect.
What patients want to understand more deeply
Why do my eyebrows drop slightly — can I avoid it?
Because the frontalis is the only elevator of the eyebrows. When it is weakened, they drop. This is not a treatment error but a direct consequence of muscle anatomy. Only the pronounced, cosmetically disturbing brow ptosis can be avoided — through sufficient distance from the orbital rim, conservative dosing and, where appropriate, co-treatment of the glabellar depressors.
What is the difference between the patterns with 4, 6 and more injection points?
Classic consensus patterns recommend 4–6 points in a horizontal line. With a tall forehead, a second line is added 1.5–2 cm above it, with 2–4 further points (8–10 points in total). The Cotofana 12-zone topography goes further: instead of fixed points, the individually active zones are treated — sometimes only 3 points, sometimes 10. Which pattern is chosen follows from the analysis of expression, not from a fixed rule.
Does the treatment work equally well on all forehead lines?
On dynamic lines (visible only during expression), very well. On static lines (also visible at rest), it reduces the depth. Very deeply etched static lines remain as a residual marking — here a hyaluronic acid filler or another skin-structure therapy can be added. The consultation assesses beforehand which line component is dynamic and which is structural.
Is the treatment done in the same appointment as the glabella?
In most cases yes — and in the same session the combined treatment of both regions takes 15–25 minutes. From a muscle-physiological point of view, simultaneous treatment is “often essential” (consensus 2007). The fee arrangement for both regions is discussed transparently during the consultation.
What do I do if I am not happy with the result after 14 days?
The follow-up appointment after 10–14 days is intended for exactly this. If brow ptosis is stronger than expected, a targeted glabellar touch-up injection can restore the muscle balance. If a Spock sign appears, a counter-Mephisto point corrects it. If the effect seems too strong — wait; it wears off naturally. An effect that is too strong cannot be “neutralised.”
Does the treatment affect my migraine?
Frequently yes — many patients report that the aesthetic forehead treatment, as a concomitant effect, reduces the frequency or intensity of migraine. The standalone migraine indication is a different treatment with the PREEMPT protocol (31–39 injection points, 155 U total dose), which in individual cases is prescription-only and is not to be equated with aesthetic forehead treatment.
What happens when the frontalis effect wears off — do the lines come back?
Yes, they return gradually as muscle activity regenerates after 3–6 months. With repeated treatment the duration often lengthens and the necessary total dose decreases gradually, because the muscle hyperactivity recedes over the long term.
Is there a minimum or maximum age?
No strict minimum age — the treatment can also be indicated in younger patients if the forehead lines are already dynamically pronounced. Likewise no maximum age — what matters is the brow position and muscle activity, not chronological age. With markedly dropped brows, however, frontalis treatment is often no longer sensible.
The scientific basis for the treatment
Consensus recommendations Sommer/Bergfeld/Sattler, 2007 — German-language consensus
Konsensusempfehlungen zum Gebrauch von Botulinumtoxin A in der ästhetischen Medizin. JDDG Supplement 1, Band 5. Describes for the forehead region: the frontalis muscle as the only eyebrow elevator, dosing ranges of 15 U (women) / 18 U (men) initial dose, a minimum distance of 1–2 cm from the orbital rim, brow ptosis as the most common adverse effect, and a recommendation for simultaneous glabellar treatment. Most of the practical statements on this page draw on this consensus.
Cotofana S & de Maio M, 2018 — anatomical 12-zone map
Botulinum toxin injection patterns for the upper face. A detailed anatomical zone map for the upper half of the face, with individualised dosing recommendations depending on muscle course, brow position and expression pattern. An important refinement of the older patterns toward more precise topography and individualised treatment. An international reference for modern frontalis treatment.
Carruthers JD & Carruthers JA, 1992 — origin of the indication
Treatment of glabellar frown lines with C. botulinum-A exotoxin. Journal of Dermatologic Surgery and Oncology, 18 (1): 17–21. Although the original description related to the glabella, the Carruthers observed from the outset the smoothing side effect on the horizontal forehead lines — and described the forehead indication in subsequent publications.
Wiest L et al. — textbook on practical implementation
Faltenbehandlung mit Botulinumtoxin A und besondere Indikationen. Springer-Lehrbuch. Describes the forehead region in detail, with injection techniques, complication management and patient guidance. In particular, the rare presentations such as the Spock sign and the Mephisto eyebrow are described with concrete correction pathways.
This selection represents the essential sources — it is not exhaustive. For the frontalis indication in particular, numerous randomised controlled trials exist on dose-finding, duration of effect and safety. The works cited here form the methodological framework for everyday clinical decisions.
Would you like to discuss the treatment in person?
The treatment page with the treatment process, duration of effect and fee information is here:
Forehead lines · Treatment overviewFor an overview of all botulinum toxin wrinkle treatments, see the category page.
For patients from the Erlangen area: wrinkle treatment near Erlangen.
Dr. med. Thomas Ackermann
Specialist in Anaesthesiology · Medical Director, Harmonie der Ästhetik
In no other region of facial-expression lines is conservative dosing as decisive as on the forehead — it is the region with the highest risk of over-treatment. The background in anaesthesiology shapes the methodical handling of dose- and time-dependent agents. This page was last reviewed on 17 May 2026.
Skin Analysis
Wrinkles & Muscle Relaxants
Bio-Regeneration (Skin Quality)
HIFU Lifting
Primary Care Support
Tension & Pain
Hair Health & Hair Loss
Skin Diseases
Drip Spa & Infusion Medicine
